Danh mục bài báo

American Society of Clinical Oncology (ASCO)

Công bố khoa học tiêu biểu của tạp chí. * Dữ liệu chỉ mang tính chất tham khảo

A randomized, double-blind, placebo-controlled, phase IIIb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)
SCIESCOPUS__Q1
American Society of Clinical Oncology (ASCO)· Tập 27 Số 18_suppl ·Trang LBA8002-LBA8002·2009
V. A. Miller, Paula G. O’Connor, Chang-Heok Soh, Fairooz F. Kabbinavar
63
Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial.
SCIESCOPUS__Q1
American Society of Clinical Oncology (ASCO)· Tập 38 Số 6_suppl ·Trang 10-10·2020
Piet Ost, Dries Reynders, Karel Decaestecker, Valérie Fonteyne, Nicolaas Lumen, Aurélie De Bruycker, Bieke Lambert, Louke Delrue, Renée Bultijnck, Els Goetghebeur, Geert Villeirs, Kathia De Man, Filip Ameye, Ignace Billiet, Steven Joniau, Friedl Vanhaverbeke, Gert De Meerleer
0
Tổng số: 1,454
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10